155 related articles for article (PubMed ID: 34007210)
1. Free Fatty Acid is a Promising Biomarker in Triage Screening for Patients with Colorectal Cancer: A Case-Control Study.
Zhu B; Zhang J; Zheng Q; Dong B; Wang M; Liu J; Cao Y
Cancer Manag Res; 2021; 13():3749-3759. PubMed ID: 34007210
[TBL] [Abstract][Full Text] [Related]
2. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
[TBL] [Abstract][Full Text] [Related]
4. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
5. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
6. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
Qian X; Wang H; Ren Z; Jin F; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
[No Abstract] [Full Text] [Related]
7. The stool
Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
[TBL] [Abstract][Full Text] [Related]
8. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
[TBL] [Abstract][Full Text] [Related]
9. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
10. Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer.
Song Y; Huang Z; Kang Y; Lin Z; Lu P; Lin Q; Cai Z; Cao Y; Zhu X
Biomed Res Int; 2018; 2018():9858943. PubMed ID: 30643826
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
12. Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer.
Li X; Guo D; Chu L; Huang Y; Zhang F; Li W; Chen J
Cancer Manag Res; 2019; 11():9631-9640. PubMed ID: 32009818
[TBL] [Abstract][Full Text] [Related]
13. [Construction of a fecal protein Luminex liquid chip detection system for early diagnosis of colorectal tumors].
Li J; Yin L; Zhang M; Xia Y; Zuo L; Liu M; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1874-1880. PubMed ID: 38081604
[TBL] [Abstract][Full Text] [Related]
14. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer.
Wang QQ; Zhou L; Qin G; Tan C; Zhou YC; Yao SK
World J Gastroenterol; 2023 Oct; 29(37):5313-5326. PubMed ID: 37899785
[TBL] [Abstract][Full Text] [Related]
16. Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients.
Kang Y; Zhu X; Lin Z; Zeng M; Shi P; Cao Y; Chen F
Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542964
[TBL] [Abstract][Full Text] [Related]
17. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer.
Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S
Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
20. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer.
Li L; Zhang L; Tian Y; Zhang T; Duan G; Liu Y; Yin Y; Hua D; Qi X; Mao Y
Front Oncol; 2019; 9():921. PubMed ID: 31649870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
